Last reviewed · How we verify
NCT06576466: SUCRE
Effect of Supplementation With Creatine on the Recovery of Ischemic Stroke
NA trial testing Creatine monohydrate in Stroke, Ischemic in 92 participants. Currently enrolling.
1 February 2027
Quick facts
| Lead sponsor | Fundació d'investigació Sanitària de les Illes Balears |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 92 |
| Start date | 27 September 2024 |
| Primary completion | 1 February 2027 |
| Estimated completion | 1 July 2027 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Creatine monohydrate — full drug profile →
- Placebo
Conditions studied
- Stroke, Ischemic — all drugs for Stroke, Ischemic →
Sponsor
Fundació d'investigació Sanitària de les Illes Balears
Who can join
Adults 18 to 80, any sex, with Stroke, Ischemic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Stroke is a leading cause of disability and the second leading cause of death worldwide. Most strokes are ischemic, caused by acute arterial occlusion. Post-stroke treatment focuses on secondary prevention and rehabilitation, but few treatments address functional recovery. Creatine, a supplement known for improving physical performance, may aid in the recovery of stroke patients, reducing sarcopenia and improving strength among other effects. This pilot study will investigate the effectiveness of creatine supplementation in enhancing physical and functional recovery in ischemic stroke patients. The study will involve a randomized, double-blind clinical trial comparing creatine monohydrate to a placebo.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06576466
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Creatine monohydrate
Trials testing the same drug.
- NCT07310043 — Creatine and Perioperative Brain Health · NA · not yet recruiting
- NCT06992414 — Exploring the Therapeutic Effects of Creatine Supplementation for Long COVID-19 · NA · not yet recruiting
- NCT06438887 — Strategic Ingestion of Creatine Supplementation and Resistance Training in Trained Young Adults · NA · recruiting
- NCT04395183 — 5-HTP and Creatine for Depression · Phase 2 · completed
- NCT05014659 — Creatine Monohydrate Supplementation and Vascular Endothelial Health · NA · completed
Other recruiting trials for Stroke, Ischemic
Currently open trials in the same condition.
- NCT07456956 — HIIT vs MCIT for Stroke-Related Sarcopenia in Ischemic Stroke · NA · recruiting
- NCT06658197 — Efficacy and Safety of Tenecteplase Bridging Mechanical Thrombectomy for Acute Large Vessel Occlusion Stroke · Phase 3 · recruiting
- NCT07282041 — Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis · Phase 2, PHASE3 · recruiting
- NCT07135089 — Improving Neuroprotective Strategy for Ischemic Stroke Before Endovascular Thrombectomy by Intravenous Tirofiban · Phase 3 · recruiting
- NCT07047014 — Advancing Reperfusion Therapy for Ischemic Stroke (ARTS): Tenecteplase in Medium Vessel Occlusion (MeVO) for Acute Ische · Phase 3 · recruiting
Other Fundació d'investigació Sanitària de les Illes Balears trials
Trials by the same sponsor.
- NCT07528937 — APPLICATION OF 3D RECONSTRUCTION FOR PREOPERATIVE STRATEGY OF LOCALLY ADVANCED COLON CANCER · NA · not yet recruiting
- NCT07011368 — Empowering Healthy Lifestyle Personalised Intervention to Prevent and Control Obesity: The HealthyW8 Project · NA · not yet recruiting
- NCT06582498 — Short Questionnaire to Assess Individual Needs in Cancer Survivors in a Clinical Setting · NA · completed
- NCT05907785 — Biomarkers of Physical Activity/health in Children and Adolescents · NA · completed
- NCT05110625 — mHealth Intervention to Prevent Type 2 Diabetes Mellitus (Phase II Study) · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06576466 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fundació d'investigació Sanitària de les Illes Balears
- Last refreshed: 8 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06576466.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing